1. Home
  2. STRS vs LENZ Comparison

STRS vs LENZ Comparison

Compare STRS & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stratus Properties Inc.

STRS

Stratus Properties Inc.

HOLD

Current Price

$26.25

Market Cap

220.4M

Sector

Real Estate

ML Signal

HOLD

Logo LENZ Therapeutics Inc.

LENZ

LENZ Therapeutics Inc.

HOLD

Current Price

$5.57

Market Cap

185.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRS
LENZ
Founded
1992
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
220.4M
185.0M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
STRS
LENZ
Price
$26.25
$5.57
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$44.00
AVG Volume (30 Days)
55.4K
876.1K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
512.50
N/A
EPS
0.82
N/A
Revenue
$29,914,000.00
$19,088,000.00
Revenue This Year
N/A
$50.42
Revenue Next Year
N/A
$197.16
P/E Ratio
$32.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.35
$5.23
52 Week High
$32.93
$50.19

Technical Indicators

Market Signals
Indicator
STRS
LENZ
Relative Strength Index (RSI) 29.95 37.06
Support Level $25.91 $5.23
Resistance Level $30.05 $10.42
Average True Range (ATR) 0.94 0.45
MACD -0.22 0.08
Stochastic Oscillator 1.00 36.73

Price Performance

Historical Comparison
STRS
LENZ

About STRS Stratus Properties Inc.

Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the entitlement, development, management, leasing, and sale of multi-family and single-family residential and commercial real estate properties in the Austin, Texas area and other select markets in Texas. The company operates in two reportable segments: Real Estate Operations and Leasing Operations. Maximum revenue is generated from the Leasing Operations segment, which involves the leasing of commercial and residential properties developed by the company. The Real Estate Operations segment comprises properties under various stages of development: developed for sale, under development, and available for development.

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.

Share on Social Networks: